Journey Medical appoints Joseph Benesch as permanent CFO effective April 26

Journey Medical Corp

Mr. Benesch had served as interim CFO since January 2023 and as Corporate Controller since November 2021.
Compensation remains unchanged; any future changes will be determined by Board/Compensation Committee.
Benesch brings over 25 years of public/private accounting and life sciences experience, including prior CFO roles at Teligent and Torrent.
CEO Claude Maraoui cited Benesch's leadership as key for upcoming milestones, including potential DFD-29 FDA decision for rosacea.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joseph Benesch

Chief Financial Officer

DERM · Journey Medical Corp

Effective: 2024-04-26
Filed: May 1, 2024, 7:59 PM ET

On April 26, 2024, the Board of Directors (the “ Board ”) of Journey Medical Corporation (the “ Company ”) appointed Joseph Benesch, age 57, as the Company’s permanent Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph Benesch was appointed as Chief Financial Officer at Journey Medical Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On April 26, 2024, the Board of Directors (the “ Board ”) of Journey Medical Corporation (the “ Company ”) appointed Joseph Benesch, age 57, as the Company’s permanent Chief Financial Officer.

View on SEC.gov

Journey Medical Corp filing history →

Source: SEC EDGAR

accession 0001104659-24-055725

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.